Dose-response curves to topically applied acetylcholine, bradykinin, and nitroprusside were obtained by intravital microscopy in arcading arterioles of the spinotrapezius muscle of control (n-9) and one-kidney, one clip hypertensive (1K1C) rats (n=ll) of 4 weeks' duration before and during superfusion with the specific inhibitor of nitric oxide formation A^-monomethyl L-arginine (LNMMA) (1(T 4 M) and both LNMMA (1(T 4 M) and indomethacin (2.8 xlO" 5 M). Resting arteriolar tone was higher in 1K1C rats than in controls, and vasodilation to acetylcholine and bradykinin, but not to nitroprusside, was reduced (p<0.05) in 1K1C rats compared with controls. LNMMA increased arteriolar tone (/><0.05) and inhibited the vasodilator responses to acetylcholine and bradykinin (/?<0.05) in controls but not in 1K1C rats. LNMMA did not alter the response to nitroprusside in either group. Addition of indomethacin to LNMMA increased arteriolar tone and markedly reduced the response to bradykinin, but not to acetylcholine or nitroprusside, in both groups. These findings suggest that resting arteriolar tone is increased in 1K1C rats partially because of the decreased basal release or synthesis of nitric oxide. Responses to the endothelium-dependent vasodilators acetylcholine and bradykinin were attenuated in 1K1C rats, possibly because of changes in synthesis or release of nitric oxide for acetylcholine and of prostacyclin for bradykinin, because the response to the endothelium-independent vasodilator nitroprusside did not differ between the groups. (Hypertension 1991;17:875-880)
dothelium-intact vascular preparations in the absence of added endothelium-dependent relaxing agents. 7 The identification of LNMMA as a specific inhibitor of this pathway has allowed the investigation of the role of NO in the regulation of blood pressure. 8 Numerous studies performed on isolated conduit arteries in vitro (primarily aorta) have demonstrated that endothelium-dependent responses are reduced in several models of chronic hypertension. 9 " 15 We have shown that arteriolar dilation to the endothelium-dependent vasodilators ACh and bradykinin (Bdk) is reduced in the spinotrapezius muscle from one-kidney, one clip Goldblatt (1K1C) hypertensive rats compared with normotensive controls. 16 In the present study, we have used LNMMA to investigate the role of endothelium-derived NO in the reduction of arteriolar responses to endothelium-dependent vasodilator agents in 1K1C hypertensive rats.
tamine hydrochloride (60 mg/kg i.p.) and xylazine (10 mg/kg i.p.) at the age of 6-7 weeks. Body weight was 180±7 g (n=9, mean±SEM) in the control group and 195±6 g (n = ll) in the hypertensive group. After an abdominal incision, the right kidney was removed, and a silver clip with a gap of 0.23 mm was placed on the left renal artery. Control rats were treated in the same manner as the hypertensive rats, except no clip was applied. Penicillin G (25,000 units i.m.) was injected after surgery. Rats were individually caged, fed rat chow and water ad libitum, and maintained on a 12-hour light/dark cycle until their use in experiments 4 weeks later.
Spinotrapezius Preparation
Rats were anesthetized with sodium thiopental (100 mg/kg i.p.). The trachea was intubated (PE-240), and the left carotid artery was cannulated (PE-90). The core temperature of the rat was maintained at 37°C with a servo-controlled heating mat. The exposed spinotrapezius muscle was maintained at 34°-35°C with warm water circulating through the base of the pedestal. The preparation was placed on the stage of a Zeiss microscope (Thornwood, N.Y.) equipped with a x 10 Nikon water immersion objective and transilluminated through a long-workingdistance condenser by a 100-W halogen lamp with a heat absorption filter in the light path. The muscle was suspended in a Krebs-Henseleit bath, the volume of which was 1.5 ml.
The preparation was allowed to equilibrate for 20 minutes before microvascular observations were begun. During the equilibration period, spinotrapezius arterioles were classified as feeding, arcade, and transverse on the basis of their location in the network. 17 When mean arterial pressure or heart rate was unstable, the experiment was terminated. Only one arcade arteriole was studied for each animal. Arterioles in which the walls were clearly visible were examined by closed-circuit television microscopy using a video image splitter to measure inside diameter. The final magnification on the video monitor was x 1,250, and the resolution with the xlO objective (numerical aperture, 0.22) was 0.67 /im. Mean arterial pressure from the left carotid artery was recorded continuously on a Brush 2200 recorder (Qeveland, Ohio) using a Statham pressure transducer (Oxnard, Calif.).
Drug Application
ACh, nitroprusside (NP), and Bdk were applied topically to the spinotrapezius muscle in 0.1-ml volumes with a calibrated automatic pipette. During the administration of vasoactive substances, the flow of Krebs-Henseleit solution, 2.0 ml/min, was not halted so that these substances were further diluted with the superfusion fluid. LNMMA was introduced into the superfusion solution through a side branch with a syringe pump at a pump speed of 0.2 ml/min to achieve the final bath concentrations indicated below.
ACh, NP, Bdk, and LNMMA were dissolved in saline and frozen and stored at -20°C for no more than 6 weeks. Indomethacin was dissolved daily in saline-sodium carbonate (9.4xlO~3 M) to give a solution of 2.8xlO 3 M, and pH was adjusted to 7.4 with hydrochloric acid. All the drugs subsequently were diluted with Krebs-Henseleit solution to the desired concentrations. LNMMA (p-hydroxyazobenzene-//-sulfonate salt) was obtained from Calbiochem Corp., La Jolla, Calif. All other drugs were obtained from Sigma Chemical Co., St. Louis, Mo.
Experimental Protocol
After an equilibration period of 20 minutes, concentration-response curves to topically applied ACh, NP, and Bdk were obtained. Then, LNMMA was continuously added to the superfusion solution, and the response was observed for 15 minutes, after which a second set of dose-response curves was measured. The superfusion solution was switched to one containing both 10~4 M LNMMA and 2.8xlO~5 M indomethacin, and the response was observed for 30 minutes. Subsequently, a third set of concentration-response curves of ACh, NP, and Bdk was obtained in the presence of both 10" 4 M LNMMA and 2.8xlO~5 M indomethacin. The concentration of each drug was increased in log increments after the arteriplar diameter had returned to the control level. Preliminary studies indicated that 2-minute intervals were sufficient for the arteriolar diameter to return to control levels. Responses reached maximal levels within 30 seconds after application of agents. The order of drugs was randomized, and applications of different drugs were separated for at least 10 minutes to ensure clearance of drug from the bath. At the end of the experiment, 0.1 ml adenosine (10~3 M) was added to the bath to achieve maximal vascular smooth muscle relaxation, and maximal vessel diameter was measured. The duration of the whole experiment did not exceed 3.5 hours.
The 
Statistical Analysis
Values are given as mean±SEM. Multiple data were analyzed by analysis of variance followed by multiple comparisons made with Duncan's new multiple range test Student's t test was used when appropriate. Statistical significance was considered to be/><0.05.
Results
Body weight at the time of the experiment was 347±8 g in control rats and 340±10 g in 1K1C rats (NS) ( Table 1 ). Mean arterial pressure was significantly (p<0.01) elevated in 1K1C rats at 182±6 mm Hg compared with normotensive control rats at 123 ±3 mm Hg. Heart rate did not differ between the groups, at 384±12 beats/min for 1K1C rats and 390 ±6 beats/min for controls. Except in one normotensive and two hypertensive animals that were excluded from the study, mean arterial pressure and heart rate did not change during the experiment. The top panel of Figure 1 shows the resting artenolar diameters for the concentration-response curves of ACh, NP, and Bdk, as well as the maximal relaxant diameter obtained with 10~3 M adenosine in normotensive and hypertensive rats. In either group, successive resting arteriolar diameters before the application of each vasoactive drug did not change significantly under the same bath conditions. The average resting arteriolar diameter in the normotensive group was 51 ±5 /mi (n=9) during the control period and decreased significantly (p<0.05) to 38±4 fim during the supervision of 10~4 M LNMMA and to 35 ±4 fim during the superfusion of both 10~4 M LNMMA and 2.8xlO" 5 M indomethacin. The average resting arteriolar diameter in the 1K1C group was 42±5 /i.m (n=ll) during the control period and did not change significantly on superfusion of LNMMA (38±5 fim). Average arteriolar diameter in hypertensive rats decreased significantly (p<0.05) to 35 ±4 (im on superfusion of both LNMMA and indomethacin compared with the control period. Maximal arteriolar diameters were 79 ±6 fim in normotensive rats and 84±7 /xm in 1K1C rats.
Resting arteriolar tone (Figure 1 , bottom panel) during the control period was significantly higher in hypertensives (50±4%) than in normotensives (36±4%). Superfusion of LNMMA raised arteriolar tone significantly (p<0.05) in normotensive (52±4%) but not in 1K1C rats (56±4%). Superfusion of both LNMMA and indomethacin increased arteriolar tone significantly (p<0.05) from control levels to 56±4% and 60±4% in normotensive and 1K1C rats, respectively. There was no significant difference in arteriolar tone between the two groups during the superfusion of LNMMA or both LNMMA and indomethacin. Figure 2 shows the effects of LNMMA and of both LNMMA and indomethacin on the concentrationresponse curves of ACh, Bdk, and NP. The vasodilator response to ACh was significantly reduced in 1K1C rats compared with nonnotensives during the control period. Superfusion of LNMMA suppressed the vasodilator response to ACh in normotensive but not in 1K1C rats. Addition of indomethacin did not alter the response in either group. There was no significant difference in the vasodilator responses to ACh between normotensive and 1K1C rats during the superfusion of LNMMA or both LNMMA and indomethacin. The vasodilator response to Bdk was significantly reduced in 1K1C rats compared with normotensives during the control period and during superfusion of LNMMA. Superfusion of LNMMA decreased the vasodilator response to Bdk significantly in normotensive but not in 1K1C rats. Addition of indomethacin suppressed the response markedly in both groups. There was no significant difference in the vasodilator responses to Bdk between normotensive and hypertensive rats during the superfusion of both LNMMA and indomethacin. The vasodilator response to NP did not differ significantly between the groups during the control period, nor did the superfusion of LNMMA or both LNMMA and indomethacin alter the response of either group.
Concentration-response curves of acetylcholine, bradykinin, and nitroprusside during control period and during superfusion of f^-monomethyl L-arginine (L-NMMA) and both L-NMMA and indomethacin (L-NMMA+INDO) in normotensive (NT) control and one-kidney, one clip Gold

Discussion
Successive topical applications of drugs did not change basal smooth muscle tone over the duration of the experiments, as indicated by the unchanged resting arteriolar diameters between dose-response curves ( Figure 1 ). Arteriolar tone, estimated from the difference between resting and maximally relaxed diameters, was significantly higher in 1K1C than in normotensive rats during the control period. Increased vasoconstriction has been reported in arterioles of cremaster and gracilis muscles in 1K1C rats of 4-6 weeks. 18 - 19 Superfusion of LNMMA reduced arteriolar diameter and increased arteriolar tone in the normotensive group, but not in 1K1C rats. The onset of action of LNMMA was nearly immediate. These findings with LNMMA suggest that endogenous biosynthesis and basal release of NO modulate resting arteriolar diameter and tone in normotensive rats; however, in 1K1C rats, basal synthesis or release of NO may be reduced, and reduction of NO release may raise vascular tone. In hypertension, all aspects of vasoconstriction seem to be enhanced, especially during the early stage of experimental hypertension when structural changes have not yet occurred. 18 Arterioles of hypertensive animals have increased sensitivity and reactivity to norepinephrine 20 and other vasoactive agents, 21 suggesting that vascular hyperresponsiveness may contribute to enhanced vasoconstriction. The basal release of endogenous NO could act as a functional antagonist to vasoconstrictors, 22 -23 and the reduction of endothelial NO release may increase the sensitivity of vascular smooth muscle to vasoconstrictive agents, leading to a rise in arteriolar tone. In fact, it has been reported that endothelial removal enhances the contractile response to a number of vasoconstrictors.
-23
Superfusion of LNMMA inhibited the vasodilator response to ACh and Bdk, but not to NP in the normotensive control, indicating that ACh and Bdk act through the formation of endogenous NO in vivo and that vasodilation to NP is independent of endothelium-derived NO in skeletal muscle arterioles. NO formed within the vascular smooth muscle cur-rently is considered to be the mediator expressing the relaxant action of NP. 4 These results are in agreement with those of Tolins et al, 24 whose results indicated that NO mediates the hemodynamic effects of ACh in vivo.
The vasodilator response to ACh was substantially inhibited but not abolished by LNMMA. These results are consistent with those obtained in vascular rings in vitro, where more LNMMA was required to inhibit ACh-induced relaxation than was required to increase basal tone. 7 At this stage, it is difficult to know whether sufficiently high concentrations of LNMMA in the microenvironment of the vascular endothelial cell were achieved at these doses to compete effectively with endogenous levels of L-arginine, or if ACh is mediated by NO arising from a pool of arginine inaccessible to LNMMA, or by an EDRF distinct from NO, such as endothelium-derived hyperpolarizing factor. 25 Because LNMMA suppressed the response to lower doses of ACh more effectively than to higher, the concentration of ACh may alter the manner in which ACh stimulates NO release.
Supervision of either indomethacin or LNMMA can separate the roles of NO and prostacyclin in endothelium-dependent vasodilation. Prostacyclin is a potent vasodilator, and endothelial cells are a major source of prostacyclin within the vessel wall. 26 ' 27 Therefore, prostacyclin released from endothelial cells can act as a dilator of smooth muscle, and stimulation of prostacyclin release from the endothelium causes endothelium-dependent relaxation. Koller et al 28 reported that light-dye treatment of rat cremasteric arterioles could damage the endothelium and produce a selective inhibition of dilator response to ACh and Bdk but not to NP. Moreover, because cyclooxygenase inhibition reduced the vasodilation to Bdk, they 28 suggest that both ACh and Bdk are endothelium-dependent vasodilators and that Bdk seems to stimulate both endothelial production of prostaglandins and release of other endotheliumderived factors. In the present study, addition of indomethacin to LNMMA in the superfusion solution did not change the response to ACh but reduced the response to Bdk markedly. These results suggest that vasodilation by Bdk could be attributable to NO and prostacyclin, with the latter having the major role. Although ACh releases prostacyclin in aortic rings, 29 indomethacin did not block the dilator response to ACh in these vessels nor in vessels from normotensive animals in other studies.
-
1314 The unchanged response to ACh after indomethacin also suggests that contracting factors produced by cyclooxygenase in response to ACh in spontaneously hypertensive rats 13 are not involved in 1K1C hypertension.
The vasodilator response to ACh during the control period and to Bdk during superfusion of LNMMA was significantly lower in 1K1C rats than in normotensive controls. There was no significant difference between the groups in their vasodilator responses to ACh during superfusion of LNMMA or their responses to Bdk during superfusion of both LNMMA and indomethacin. These results indicate that synthesis or release of endothelium-derived NO and vasodilator prostaglandins, stimulated by ACh and Bdk, respectively, are reduced in 1K1C rats and that the endothelial dysfunction may occur in a nonspecific manner. Theoretically, the relaxations could be depressed because of decreased release or synthesis of mediators from the endothelium or decreased responsiveness of the vascular smooth muscle to the mediators. Because the response to NP did not differ between normotensive and 1K1C rats, it is unlikely that the reduction of endotheliumdependent relaxation in 1K1C rats results from changes in vascular smooth muscle reactivity.
Chronic hypertension in all animal models studied reportedly is associated with morphological changes in the endothelium of aorta or large arteries.
10 A dynamic remodeling of rat skeletal muscle arterioles has been demonstrated during the development of hypertension, with marked structural reduction in arteriolar diameters and density in rats with 1K1C hypertension. 1819 Recently, Hansen-Smith et al 30 reported atrophy and degeneration of endothelial cells in skeletal muscle arterioles from rats with chronic reduced renal mass hypertension, and they suggested that the observed structural changes occur during the process of microvascular remodeling. A study using rats with aortic coarctation showed that pressure-or flow-dependent mechanisms were responsible for this remodeling, 31 and it is likely that endothelial function may be affected by changes in either microvascular pressure or blood flow (shear stress). Furthermore, the renin-angiotensin system, mineralocorticoid hormones, and catecholamines, as well as high salt intake, have been implicated in hypertensive vascular injury, 9 -32 - 33 suggesting that neurohumoral factors also may contribute to the endothelial dysfunction in hypertension.
In conclusion, arteriolar responses to the endothelium-dependent vasodilators ACh and Bdk were attenuated in 1K1C rats, possibly because of changes in synthesis or release of endothelium-derived NO and prostacyclin, because the response to the endothelium-independent vasodilator NP was unchanged. Indomethacin attenuated the vasodilation by Bdk, which implicates a partial role of prostacyclin for its action in vivo. Decreased basal release of endothelium-derived vasodilators may contribute to increased vascular tone in this model of renal hypertension.
